QURE peer analysis
uniQure (QURE) against its competitors: price, today's move, 1-year return and market value side by side.
QURE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| FDMT 4D Molecular | $11.28 | -5.21% | -0.35% | – |
| MGTX MeiraGTx | $9.49 | -2.22% | 8.71% | $911.45M |
| NGNE Neurogene | $27.55 | -4.41% | -16.87% | – |
| RARE Ultragenyx | $16.43 | 2.05% | -53.28% | $1.59B |
| RCKT Rocket Pharmaceuticals | $2.44 | -3.94% | -34.05% | $267.85M |
| RGNX REGENXBIO | $7.20 | -2.83% | -43.84% | $475.29M |
| VYGR Voyager Therapeutics | $1.72 | -2.27% | -61.95% | $105.98M |
| QURE uniQure | $23.32 | -6.08% | -65.64% | $1.72B |
- QURE's peers: FDMT (4D Molecular), MGTX (MeiraGTx), NGNE (Neurogene), RARE (Ultragenyx), RCKT (Rocket Pharmaceuticals), RGNX (REGENXBIO), VYGR (Voyager Therapeutics).
Updated 2026-11-02 19:14 UTC